PTC Inc. stock is a Buy as Creo & Windchill drive R&D lock-in, 27% RPO growth, and 95% recurring revenue, plus $365M buybacks. Click here to read more on PTC.
Creatives want toned-down exteriors and more color-accurate displays. But AI is pushing GPU performance up the priority ...
Post-doc Computer-Aided Drug Design. The successful candidate will develop and apply Computer-Aided Drug Design (CADD) methodologies to advance drug discovery projects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results